Hannah Joseph Hospital IPO
Hannah Joseph Hospital IPO Details
-
Open Date
22 Jan 2026
-
Close Date
27 Jan 2026
-
Listing Date
30 Jan 2026
- IPO Price Range
₹ 67 to ₹70
- IPO Size
₹ 42 Cr
- Listing Exchange
BSE SME
Hannah Joseph Hospital IPO Timeline
Hannah Joseph Hospital IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 22-Jan-2026 | 0.00 | 0.68 | 0.06 | 0.18 |
| 23-Jan-2026 | 0.63 | 1.05 | 0.22 | 0.51 |
Last Updated: 23 January 2026 5:40 PM by 5paisa
Founded in 2008 in Madurai, Tamil Nadu, Hannah Joseph Hospital began as a sole proprietorship with a focus on delivering specialized neurosurgery and neurology care. The hospital was incorporated as Hannah Joseph Hospital Private Limited in 2011 and later converted into a public limited company in 2022. Promoted by Dr. Mosesjoseph Arunkumar, a practicing neurosurgeon, and Dr. Fenn Kavitha Fenn Arunkumar, a consultant psychiatrist, the hospital has evolved into a multi-speciality healthcare provider. In 2020, it relocated to a larger two-acre campus to support expansion, and currently operates a centrally air-conditioned facility with modern infrastructure and a total capacity of 150 beds.
Established in: 2008
Managing Director: Dr. Moses Joseph Arunkumar
Peers:
Asarfi Hospital Limited
Maitreya Medicare Limited
Hannah Joseph Hospital Objectives
1. Capital expenditure for setting up a Radiation Oncology Centre ₹34.98 crore
2. Utilisation of funds for general corporate purposes
Hannah Joseph Hospital IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹42 Cr |
| Offer For Sale | - |
| Fresh Issue | ₹42 Cr |
Hannah Joseph Hospital IPO Lot Size
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 4000 | 2,68,000 |
| Retail (Max) | 2 | 4000 | 2,80,000 |
| S-HNI (Min) | 3 | 6000 | 4,02,000 |
| S-HNI (Max) | 7 | 14000 | 9,80,000 |
| B-HNI (Min) | 8 | 16000 | 10,72,000 |
Hannah Joseph Hospital IPO Reservation
| Investors Category | Subscription (times) | Shares Offered* | Shares bid for | Total Amount (Cr.)* |
|---|---|---|---|---|
| QIB (Ex Anchor) | 0.63 | 11,40,000 | 7,16,000 | 5.012 |
| Non-Institutional Buyers | 1.05 | 8,58,000 | 9,04,000 | 6.328 |
| bNII (bids above ₹10L) | 1.49 | 5,72,000 | 8,52,000 | 5.964 |
| sNII (bids below ₹10L) | 0.18 | 2,86,000 | 52,000 | 0.364 |
| Individual Investors (IND category bidding for 2 Lots) | 0.22 | 19,96,000 | 4,36,000 | 3.052 |
| Total** | 0.51 | 39,94,000 | 20,56,000 | 14.392 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Revenue | 54.62 | 63.40 | 77.53 |
| EBITDA | 16.38 | 17.97 | 20.51 |
| PAT | 1.01 | 4.06 | 7.20 |
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Total Assets | 92.14 | 89.97 | 99.29 |
| Share Capital | 16.34 | 16.69 | 16.69 |
| Total Liabilities | 42.95 | 31.39 | 33.58 |
| Cash Flows (₹ Crores) | FY23 | FY24 | FY25 |
| Net Cash Generated From / (used in) Operating Activities | 20.81 | 8.04 | 19.60 |
| Net Cash Generated From / (used in) Investing Activities | -4.96 | -3.60 | -13.49 |
| Net Cash Generated From / (used in) Financing Activities | -10.43 | -2.62 | -3.18 |
| Net Increase (Decrease) in Cash and Cash Equivalents | 5.42 | 1.82 | 2.94 |
Strengths
1. Strategic location supporting accessibility and patient inflow
2. Leadership under a highly reputed and experienced neurosurgeon
3. Comprehensive neurological institute aligned with international clinical standards
4. Proven track record of managing complex surgeries with high success rates
Weaknesses
1. Presence limited to a specific geographic region
2. High capital requirement for procuring and maintaining advanced medical equipment
3. Operational and infrastructure challenges in scaling into a full multi-specialty hospital
4. Risk of reputational impact due to potential lapses in service quality.
Opportunities
1. Scope to expand operations into new regions and underserved markets
2. Potential to establish facilities in Tier II and Tier III cities
3. Partnerships with other healthcare institutions for clinical and knowledge collaboration
4. Adoption of emerging medical technologies and digital healthcare solutions
Threats
1. Availability and retention of skilled medical and support staff
2. Cost pressures arising from expectations of affordable and universal healthcare
3. Need for strict financial discipline and efficient budget management
4. Compliance with evolving healthcare regulations and statutory requirements
1. Rapidly growing multi-speciality hospital with a strong footprint in South Tamil Nadu
2. Recognised centre for advanced neurosciences and complex surgical care
3. Expanded capabilities in cardiology with angioplasty and open-heart surgeries
4. NABH and NABL accreditations ensuring high clinical and diagnostic standards
5. Led by experienced medical promoters with decades of healthcare expertise
1. Focused on building a high-quality healthcare ecosystem through advanced medical practices and modern infrastructure
2. Strong emphasis on standardized processes and digital patient management to improve care efficiency
3. Backed by a skilled team of doctors, consultants, and specialists with proven clinical expertise
4. Clear strategy to attract and retain reputed medical professionals to strengthen service depth
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Hannah Joseph Hospital IPO opens from January 22, 2026 to January 27, 2026.
The size of Hannah Joseph Hospital IPO is approximately ₹42 crore.
The price band of Hannah Joseph Hospital IPO is fixed at ₹67 to ₹70 per share.
To apply for Hannah Joseph Hospital IPO, follow the steps given below:
● Login to your 5paisa demat account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Hannah Joseph Hospital. IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size is 4000 shares, requiring an investment of approximately ₹2,68,000.
The share allotment date of Hannah Joseph Hospital IPO is January 28, 2026.
The Hannah Joseph Hospital IPO will likely be listed on January 30, 2026.
Capital Square Advisors Pvt.Ltd is the book-running lead manager.
1. Investment towards establishing a Radiation Oncology Centre with modern infrastructure ₹34.98 crore
2. Allocation of proceeds for general business and corporate requirements